Skip to main content
NCBI home page
The Journal of Headache and Pain logoLink to The Journal of Headache and Pain
. 2008 Jul 31;9(5):267–276. doi: 10.1007/s10194-008-0058-2

Serotonin and migraine: a reconsideration of the central theory

Alessandro Panconesi 1,2,✉
PMCID: PMC3452194  PMID: 18668197

Abstract

The 5-hydroxytryptamine (5-HT) has been implicated in migraine pathophysiology for the past 50 years. A low central 5-HT disposition associated with an increase in 5-HT release during attack is the most convincing change of 5-HT metabolism implicated in migraine. Peripheral studies on plasma/platelet have not generally shown low 5-HT levels. Studies on 5-HT reactivity showed hypersensitivity, also expressed as reduced tachyphylaxis (habituation), which successively was evidenced as the most characteristic marker of an altered sensory neurotransmission. Even the gender and seasonal variations of 5-HT parameters seem to agree with a low 5-HT turnover with receptoral hypersensitivity. The interpretation of the effects of some serotonergic drugs and recent neuroimaging studies give major evidence for this cascade of events. Although the exact mechanism that links abnormal 5-HT neurotransmission to the manifestation of head pain has yet to be fully understood, a deficit on 5-HT descending pain inhibitory system is still probably today the most implicated in migraine pathophysiology. This short review focuses and discusses the alteration of peripheral and central 5-HT parameters in migraine patients.

Keywords: Migraine, 5-Hydroxytryptamine, Gender differences, Seasons, 5-HT release, Habituation

Full Text

The Full Text of this article is available as a PDF (293.6 KB).

Conflict of interest

None.

References

  • 1.Panconesi A. 5-Hydroxytryptamine parameters in the periphery: how useful are they in the study of headaches? J Serotonin Res. 1995;2:117–137. [Google Scholar]
  • 2.Sicuteri F, Testi A, Anselmi B. Biochemical investigations in headache: increase in the hydroxyndoleacetic acid excretion during migraine attacks. Int Arch Allergy Appl Immunol. 1961;19:55–58. [Google Scholar]
  • 3.Sicuteri F. Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity) Headache. 1972;12:69–72. doi: 10.1111/j.1526-4610.1972.hed1202069.x. [DOI] [PubMed] [Google Scholar]
  • 4.Sicuteri F. Hypothesis: migraine, a central biochemical dysnociception. Headache. 1976;16:145–159. doi: 10.1111/j.1526-4610.1976.hed1604145.x. [DOI] [PubMed] [Google Scholar]
  • 5.Jans LAW, Riedel WJ, Markus CR, Blokland A. Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry. 2007;12:522–543. doi: 10.1038/sj.mp.4001920. [DOI] [PubMed] [Google Scholar]
  • 6.Panconesi A, Sicuteri R. Headache induced by serotonergic agonists––a key to the interpretation of migraine pathogenesis? Cephalalgia. 1997;17:3–14. doi: 10.1046/j.1468-2982.1997.1701003.x. [DOI] [PubMed] [Google Scholar]
  • 7.Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007;27:1295–1300. doi: 10.1111/j.1468-2982.2007.01476.x. [DOI] [PubMed] [Google Scholar]
  • 8.Montagna P. The primary headaches: genetics, epigenetics and behavioural genetic model. J Headache Pain. 2008;9:57–69. doi: 10.1007/s10194-008-0026-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Uebelhack R, Franke L, Herold N, Plotkin M, Amthauer H, Felix R. Brain and platelet serotonin transporter in humans––correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci Lett. 2006;406:153–158. doi: 10.1016/j.neulet.2006.06.004. [DOI] [PubMed] [Google Scholar]
  • 10.Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 1993;13:151–165. doi: 10.1046/j.1468-2982.1993.1303151.x. [DOI] [PubMed] [Google Scholar]
  • 11.Waldenlinden E, Ross SB, Saaf J, Ekbom K, Wetterberg L. Concentration and uptake of 5-hydroxytryptamine in platelets from cluster headache and migraine patients. Cephalalgia. 1985;5:45–54. doi: 10.1046/j.1468-2982.1985.0501045.x. [DOI] [PubMed] [Google Scholar]
  • 12.Shukla R, Shanker K, Nag D, Verma M, Bhargava KP. Serotonin in tension headache. J Neurol Neurosurg Psychiatry. 1987;50:1682–1684. doi: 10.1136/jnnp.50.12.1682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Takeshima T, Shimomura T, Takahashi K. Platelet activation in muscle contraction headache and migraine. Cephalalgia. 1987;7:239–243. doi: 10.1046/j.1468-2982.1987.0704239.x. [DOI] [PubMed] [Google Scholar]
  • 14.Anthony M, Lance JW. Plasma serotonin in patients with chronic tension headaches. J Neurol Neurosurg Psychiatry. 1989;52:182–184. doi: 10.1136/jnnp.52.2.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ferrari MD, Odink J, Tapparelli C, Kempen GMJ, Pennings EJM, Bruyn GW. Serotonin metabolism in migraine. Neurology. 1989;39:1239–1242. doi: 10.1212/wnl.39.9.1239. [DOI] [PubMed] [Google Scholar]
  • 16.Nakano T, Shimomura T, Takahashi K, Ikawa S. Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache. Headache. 1993;33:528–532. doi: 10.1111/j.1526-4610.1993.hed3310528.x. [DOI] [PubMed] [Google Scholar]
  • 17.D’Andrea G, Hasselmark L, Alecci M, Cananzi A, Perini F, Welch KM. Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura. J Neurol Neurosurg Psychiatry. 1994;57:557–561. doi: 10.1136/jnnp.57.5.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.D’Andrea G, Cananzi AR, Perini F, Hasselmark L. Platelets models and their possible usefulness in the study of migraine pathogenesis. Cephalalgia. 1995;15:265–271. doi: 10.1046/j.1468-2982.1995.1504265.x. [DOI] [PubMed] [Google Scholar]
  • 19.Kitano A, Shimomura T, Takeshima T, Takahashi K. Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. Headache. 1994;34:515–518. doi: 10.1111/j.1526-4610.1994.hed3409515.x. [DOI] [PubMed] [Google Scholar]
  • 20.Srikiatkhachorn A, Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 1996;16:423–426. doi: 10.1046/j.1468-2982.1996.1606423.x. [DOI] [PubMed] [Google Scholar]
  • 21.Stronks DL, Tulen JH, Verheij R, Boomsma F, Fekkes D, Pepplinkhuizen L, Mantel GW, Passchier J. Serotonergic, cathecolaminergic, and cardiovascular reactions to mental stress in female migraine patients. A controlled study. Headache. 1998;38:270–280. doi: 10.1046/j.1526-4610.1998.3804270.x. [DOI] [PubMed] [Google Scholar]
  • 22.Evers S, Quibeldey F, Grotemeyer K-H, Suhr B, Husstedt I-W. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia. 1999;19:485–491. doi: 10.1046/j.1468-2982.1999.019005485.x. [DOI] [PubMed] [Google Scholar]
  • 23.Jerney B, Vladic A, Cicin-Sain L, Hranilovic D, Banovic M, Balija M, Bilic E, Sucic Z, Vukadin S, Grgicevic D. Platelet serotonin measures in migraine. Headache. 2002;42:588–595. doi: 10.1046/j.1526-4610.2002.02145.x. [DOI] [PubMed] [Google Scholar]
  • 24.Juhasz G, Zsombok T, Laszik A, Jakus R, Faludi G, Sotonyi P, Bagdy G. Despite the general correlation of the serotonin transporter gene regulatory region polymorphism (5-HTTLPR) and platelet serotonin concentration, lower platelet serotonin concentration in migraine patients is independent of the 5-HTTLPR variants. Neurosci Lett. 2003;350:56–60. doi: 10.1016/S0304-3940(03)00834-6. [DOI] [PubMed] [Google Scholar]
  • 25.Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology. 2005;65:620–622. doi: 10.1212/01.wnl.0000172339.15577.a6. [DOI] [PubMed] [Google Scholar]
  • 26.Bendtsen L, Mellerup ET. The platelet serotonin transporter in primary headaches. Eur J Neurol. 1998;5:277–282. doi: 10.1046/j.1468-1331.1998.530277.x. [DOI] [PubMed] [Google Scholar]
  • 27.Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;106:461–470. doi: 10.1016/j.pain.2003.09.008. [DOI] [PubMed] [Google Scholar]
  • 28.Rolf LH, Wiele G, Brune GG. 5-Hydroxytryptamine in platelets of patients with muscle contraction headache. Headache. 1981;21:10–11. doi: 10.1111/j.1526-4610.1981.hed2101010.x. [DOI] [PubMed] [Google Scholar]
  • 29.Shimomura T, Takahashi K. Alteration of platelet serotonin in patients with chronic tension-type headache during cold pressor test. Headache. 1990;30:581–583. doi: 10.1111/j.1526-4610.1990.hed3009581.x. [DOI] [PubMed] [Google Scholar]
  • 30.Leira R, Castillo J, Martinez F, Prieto JM, Noya M. Platelet-rich plasma serotonin levels in tension-type headache and depression. Cephalalgia. 1993;13:346–348. doi: 10.1046/j.1468-2982.1993.1305346.x. [DOI] [PubMed] [Google Scholar]
  • 31.Jensen R, Hindberg I. Plasma serotonin increase during episodes of tension-type headache. Cephalalgia. 1994;14:219–222. doi: 10.1046/j.1468-2982.1994.014003219.x. [DOI] [PubMed] [Google Scholar]
  • 32.D’Andrea G, Hasselmark L, Cananzi AR, Alecci M, Perini F, Zamberlan F, Welch KMA. Metabolism and menstrual cycle rhythmicity of serotonin in primary headache. Headache. 1995;35:216–221. doi: 10.1111/j.1526-4610.1995.hed3504216.x. [DOI] [PubMed] [Google Scholar]
  • 33.Mazzotta G, Sarchielli P, Gaggioli A, Gallai V. Study of pressure pain and cellular concentration of neurotransmitters related to nociception in episodic tension-type headache patients. Headache. 1997;37:565–571. doi: 10.1046/j.1526-4610.1997.3709565.x. [DOI] [PubMed] [Google Scholar]
  • 34.Bendtsen L, Jensen R, Hindberg I, Gammeltoft S, Olesen J. Serotonin metabolism in chronic tension-type headache. Cephalalgia. 1997;17:843–848. doi: 10.1046/j.1468-2982.1997.1708843.x. [DOI] [PubMed] [Google Scholar]
  • 35.Sarchielli P, Alberti A, Russo S, Codini M, Panico R, Floridi A, Gallai V. Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia. 1999;19:810–816. doi: 10.1046/j.1468-2982.1999.1909810.x. [DOI] [PubMed] [Google Scholar]
  • 36.Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 2008;64:1–8. doi: 10.1007/s00228-007-0391-4. [DOI] [PubMed] [Google Scholar]
  • 37.Panconesi A, Anselmi B, Curradi C, Del Bianco PL, Franchi G, Sicuteri F, Tarquini B. Biological rhythms of vascular reactivity to serotonin in man. In: Halberg F, Reale L, Tarquini B, editors. Proceedings of the II international symposium on chronobiologic approach to social medicine. Rome: Istituto Italiano di Medicina Sociale; 1986. pp. 701–714. [Google Scholar]
  • 38.Dignan RJ, Yeh T, Jr, Dike CM, Lutz HA, III, Wechsler AS. The influence of age and sex on human internal mammary artery size and reactivity. Ann Thorac Surg. 1992;53:792–797. doi: 10.1016/0003-4975(92)91438-f. [DOI] [PubMed] [Google Scholar]
  • 39.Mong K, Duggan JA, Tabrizchi R. Comparative study of functional responses and morphometric state of distal radial arteries in male and female. Ann Thorac Surg. 2002;74:2126–2131. doi: 10.1016/S0003-4975(02)03984-X. [DOI] [PubMed] [Google Scholar]
  • 40.Weiss LA, Abney M, Cook EH, Jr, Ober C. Sex-specific genetic architecture of blood serotonin levels. Am J Hum Genet. 2005;76:33–41. doi: 10.1086/426697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62:847–855. doi: 10.1016/j.biopsych.2007.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, Diksic M. Cortical trapping of α-[11C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. NeuroImage. 2006;33:815–824. doi: 10.1016/j.neuroimage.2006.08.004. [DOI] [PubMed] [Google Scholar]
  • 43.Heninger GR. Serotonin, sex, and psychiatric illness. Proc Natl Acad Sci. 1997;94:4823–4824. doi: 10.1073/pnas.94.10.4823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nishizava S, Benkelfat C, Young SN, Leyton M, Mzengeza S, Montigny C, Blier P, Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci. 1997;94:5308–5313. doi: 10.1073/pnas.94.10.5308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Chugani DC, Muzik O, Chakraborty P, Magner T, Chugani HT. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-l-tryptophan. Synapse. 1998;28:33–43. doi: 10.1002/(SICI)1098-2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  • 46.Centeno ML, Reddy AP, Smith LJ, Sanchez RL, Henderson JA, Salli NC, Hess DJ, Pau FKY, Bethea CL. Serotonin in microdialysate from mediobasal hypothalamus increases after progesterone administration to estrogen primed macaques. Eur J Pharmacol. 2007;555:67–75. doi: 10.1016/j.ejphar.2006.10.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Marrelli A, Marini C, Prencipe M. Seasonal and meteorological factors in primary headaches. Headache. 1988;28:111–113. doi: 10.1111/j.1526-4610.1988.hed2802111.x. [DOI] [PubMed] [Google Scholar]
  • 48.Cugini P, Romit A, Di Palma L, Giacovazzo M. Common migraine as a weekly and seasonal headache. Chronobiol Int. 1990;7:467–469. doi: 10.3109/07420529009059158. [DOI] [PubMed] [Google Scholar]
  • 49.Robbins L. Precipitating factors in migraine: a retrospective review of 494 patients. Headache. 1994;34:214–216. doi: 10.1111/j.1526-4610.1994.hed3404214.x. [DOI] [PubMed] [Google Scholar]
  • 50.Fox AW, Davis RL. Migraine chronobiology. Headache. 1998;38:436–441. doi: 10.1046/j.1526-4610.1998.3806436.x. [DOI] [PubMed] [Google Scholar]
  • 51.Rieder A, Lobentanz I, Zeitlhofer J, Mitsche N, Lawrence K, Schwarz B, Kunze M. Background morbidity of headache in an adult general population. Results of the Austrian SERMO (self-reported morbidity) study. Wien Klin Wochenschr. 2004;116:176–181. doi: 10.1007/BF03040484. [DOI] [PubMed] [Google Scholar]
  • 52.Soriani S, Fiumana E, Manfredini R, Boari B, Battistella PA, Canetta E, Pedretti S, Borgna-Pignatti C. Circadian and seasonal variation of migraine attacks in children. Headache. 2006;46:1571–1574. doi: 10.1111/j.1526-4610.2006.00613.x. [DOI] [PubMed] [Google Scholar]
  • 53.Alstadhaug KB, Bekkelund S, Salvesen R. Circannual periodicity of migraine? Eur J Neurol. 2007;14:983–988. doi: 10.1111/j.1468-1331.2007.01828.x. [DOI] [PubMed] [Google Scholar]
  • 54.Brewerton TD. Seasonal variation of serotonin function in humans: research and clinical implications. Ann Clin Psychiatry. 1989;1:153–164. doi: 10.3109/10401238909149974. [DOI] [Google Scholar]
  • 55.Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360:1840–1842. doi: 10.1016/S0140-6736(02)11737-5. [DOI] [PubMed] [Google Scholar]
  • 56.Neumeister A, Pirker W, Willeit M, Praschak-Rieder N, Asenbaum S, Brucke T, Kasper S. Seasonal variation in availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psichiatry. 2000;47:158–160. doi: 10.1016/S0006-3223(99)00241-3. [DOI] [PubMed] [Google Scholar]
  • 57.Sicuteri F, Panconesi A, Franchi G, Del Bianco PL, Anselmi B. Impaired 5-hydroxytryptamine tachyphylaxis in migraine. Cephalalgia. 1983;3:139–142. doi: 10.1046/j.1468-2982.1983.0303139.x. [DOI] [PubMed] [Google Scholar]
  • 58.Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatr. 1993;33:173–187. doi: 10.1016/0006-3223(93)90137-3. [DOI] [PubMed] [Google Scholar]
  • 59.Ambrosini A, Noordhout AM, Sandor PS, Schoenen J. Electrophysiological studies in migraine: a comprehensive review of their interest and limitations. Cephalalgia. 2003;23(Suppl 1):13–31. doi: 10.1046/j.1468-2982.2003.00571.x. [DOI] [PubMed] [Google Scholar]
  • 60.Ambrosini A, Rossi P, Pasqua V, Pierelli F, Schoenen J. Lack of habituation causes high intensity dependance of auditory evoked cortical potentials in migraine. Brain. 2003;126:2009–2015. doi: 10.1093/brain/awg206. [DOI] [PubMed] [Google Scholar]
  • 61.Magis D, Ambrosini A, Bendtsen L, Ertas M, Kaube H, Schoenen J, (EUROHEAD project) Evaluation and proposal for optimalization of neurophysiological tests in migraine: part 1-electrophysiological tests. Cephalalgia. 2007;27:1323–1338. doi: 10.1111/j.1468-2982.2007.01440.x. [DOI] [PubMed] [Google Scholar]
  • 62.Coppola G, Ambrosini A, Di Clemente L, Magis D, Fumal A, Gerard P, Pierelli F, Schoenen J. Interictal abnormalities of gamma band activity in visual evoked responses in migraine: an indication of thalamocortical dysrhythmia? Cephalalgia. 2007;27:1360–1367. doi: 10.1111/j.1468-2982.2007.01466.x. [DOI] [PubMed] [Google Scholar]
  • 63.Judit A, Sandor PS, Schoenen J. Habituation of visual and intensity dependence of auditory evoked cortical potentials tends to normalize just before and during the migraine attack. Cephalalgia. 2000;20:714–719. doi: 10.1046/j.1468-2982.2000.00122.x. [DOI] [PubMed] [Google Scholar]
  • 64.Kropp P, Gerber W-D. Contingent negative variation during migraine attack and interval: evidence for normalization of slow cortical potentials during the attack. Cephalalgia. 1995;15:123–128. doi: 10.1046/j.1468-2982.1995.015002123.x. [DOI] [PubMed] [Google Scholar]
  • 65.Sicuteri F, Poggioni M, Panconesi A. Upregulation of pain transmission from deficient serotonergic analgesia in migraine. In: Paoletti R, Vanhoutte PM, Brunello N, Maggi FM, editors. Serotonin: from cell biology to pharmacology and therapeutics. Dordrecht: Kluwer; 1990. pp. 391–404. [Google Scholar]
  • 66.Huber D, Henrich G, Gundel H. Psychophysiological response patterns of migraine patients in two habituation tests. Headache. 2005;45:1375–1387. doi: 10.1111/j.1526-4610.2005.00270.x. [DOI] [PubMed] [Google Scholar]
  • 67.Ozkul Y, Ay H. Habituation of sympathetic skin response in migraine and tension type headache. Auton Neurosci. 2007;134:81–84. doi: 10.1016/j.autneu.2007.02.006. [DOI] [PubMed] [Google Scholar]
  • 68.Iversen HK, Olesen J. Experimental headache. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press; 1993. pp. 145–151. [Google Scholar]
  • 69.Del Bene E, Anselmi B, Del Bianco PL, Fanciullacci M, Galli P, Salmon S, Sicuteri F. Fenfluramine headache: a biochemical and monoamine receptorial human study. In: Sicuteri F, editor. Headache: new vistas. Florence: Biomedical Press; 1997. pp. 101–109. [Google Scholar]
  • 70.Sicuteri F. Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm. 1971;3:401–407. doi: 10.1016/0031-6989(71)90012-9. [DOI] [Google Scholar]
  • 71.Nattero G, Lisino F, Brandi G, Gastaldi L. Reserpine in the prevention of migraine and in the therapy of tension-vascular headache. Minerva Med. 1976;67:1871–1875. [PubMed] [Google Scholar]
  • 72.Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ. D, L-Fenfluramine challenge test: experience in nonpatient sample. Biol Psychiatry. 1996;39:761–768. doi: 10.1016/0006-3223(95)00227-8. [DOI] [PubMed] [Google Scholar]
  • 73.Brewerton TD, Murphy DL, Mueller EA, Jimerson DC. Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther. 1988;43:605–609. doi: 10.1038/clpt.1988.83. [DOI] [PubMed] [Google Scholar]
  • 74.Brewerton TD, Murphy DL, Lesem MD, Brandt HA, Jimerson DC. Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache. 1992;32:217–222. doi: 10.1111/j.1526-4610.1992.hed3205217.x. [DOI] [PubMed] [Google Scholar]
  • 75.Gordon ML, Lipton RB, Brown S-L, Nakraseive C, Russell M, Pollack SZ, Korn ML, Merriam A, Solomon S, Praag HM. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia. 1993;13:400–405. doi: 10.1046/j.1468-2982.1993.1306400.x. [DOI] [PubMed] [Google Scholar]
  • 76.Gijsman HJ, Gerven JMA, Tieleman MC, Schoemaker RC, Pieters MSM, Ferrari MD, Cohen AF, Kempen GMJ. Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. J Clin Psychopharmacol. 1988;18:289–295. doi: 10.1097/00004714-199808000-00007. [DOI] [PubMed] [Google Scholar]
  • 77.Leone M, Attanasio A, Croci D, Filippini G, D’Amico D, Grazzi L, Nespolo A, Bussone G. The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: a controlled study. Neurology. 2000;55:136–139. doi: 10.1212/wnl.55.1.136. [DOI] [PubMed] [Google Scholar]
  • 78.Feuchtl A, Bagli M, Stephan R, Frahnert C, Kolsch H, Kuhn K-U, Rao ML. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile. Pharmacopsychiatry. 2004;37:180–188. doi: 10.1055/s-2004-827175. [DOI] [PubMed] [Google Scholar]
  • 79.Leone M, Attanasio A, Croci D, Ferraris A, D’Amico D, Grazzi L, Nespolo MA, Bussone G. 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Neuroreport. 1988;9:2605–2608. doi: 10.1097/00001756-199808030-00033. [DOI] [PubMed] [Google Scholar]
  • 80.Rothman RB, Baumann MH. Serotonin re leasing agents. Neurochemical, therapeutic and adverse effects. Pharmacol Biochem Behav. 2002;71:825–836. doi: 10.1016/S0091-3057(01)00669-4. [DOI] [PubMed] [Google Scholar]
  • 81.Baylen CA, Rosemberg H. A review of the acute subjective effects of MDMA/ectasy. Addiction. 2006;101:933–947. doi: 10.1111/j.1360-0443.2006.01423.x. [DOI] [PubMed] [Google Scholar]
  • 82.Moja PL, Cusi C, Sterzi RR, Canepari C (2007) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headache. The Cochrane Library 4:1–50 [DOI] [PubMed]
  • 83.Tomkins GE, Jackson JL, O’Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressant: a meta-analysis. Am J Med. 2001;111:54–63. doi: 10.1016/S0002-9343(01)00762-8. [DOI] [PubMed] [Google Scholar]
  • 84.Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotonin reuptake inhibition. Pain. 2004;108:108–114. doi: 10.1016/j.pain.2003.12.012. [DOI] [PubMed] [Google Scholar]
  • 85.Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev. 1994;46:157–203. [PubMed] [Google Scholar]
  • 86.Moore P, Landolt H-P, Seifritz E, Clark C, Bhatti T, Kelsoe J, Rapaport M, Gillin JC. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology. 2000;23:601–622. doi: 10.1016/S0893-133X(00)00161-5. [DOI] [PubMed] [Google Scholar]
  • 87.Plasse G, Meerkerk DJ, Lieben CKJ, Blokland A, Feenstra MGP. Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion. Psychopharmacology. 2007;195:377–385. doi: 10.1007/s00213-007-0908-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Fusar-Poli P, Allen P, McGuire P, Placentino A, Cortesi M, Perez J. Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature. Psychopharmacology. 2006;188:131–143. doi: 10.1007/s00213-006-0493-1. [DOI] [PubMed] [Google Scholar]
  • 89.Drummond PD. Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia. 2006;26:1225–1233. doi: 10.1111/j.1468-2982.2006.01212.x. [DOI] [PubMed] [Google Scholar]
  • 90.Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, Munz DL, Arnold G. Increased serotonin transporter availability in the brainstem of migraineurs. J Neurol. 2007;254:789–796. doi: 10.1007/s00415-006-0444-0. [DOI] [PubMed] [Google Scholar]
  • 91.Chugani DC, Niimura K, Chaturvedi S, Muzik O, Fakkouri M, Lee ML, Chugani HT. Increased brain serotonin synthesis in migraine. Neurology. 1999;53:1473–1479. doi: 10.1212/wnl.53.7.1473. [DOI] [PubMed] [Google Scholar]
  • 92.Sakai Y, Dobson C, Diksic M, Aubè M, Hamel E. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology. 2008;70:431–439. doi: 10.1212/01.wnl.0000299095.65331.6f. [DOI] [PubMed] [Google Scholar]
  • 93.Diksic M, Sakai Y, Nishikawa M, Hamel E, Aubé M. Female migraine patients exhibit lower brain serotonin (5-HT) synthesis interictally than female controls. Cephalalgia. 2008;28:440. [Google Scholar]
  • 94.Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradrenergic and serotonergic systems in the spinal cord. J Pharmacol Sci. 2006;101:107–117. doi: 10.1254/jphs.CRJ06008X. [DOI] [PubMed] [Google Scholar]
  • 95.Sommer C. Is serotonin hyperalgesic or analgesic? Curr Pain Head Rep. 2006;10:101–106. doi: 10.1007/s11916-006-0020-4. [DOI] [PubMed] [Google Scholar]
  • 96.Hamel E. Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol. 2006;100:1059–1065. doi: 10.1152/japplphysiol.00954.2005. [DOI] [PubMed] [Google Scholar]
  • 97.Strassman AM, Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006;95:1298–1306. doi: 10.1152/jn.01293.2005. [DOI] [PubMed] [Google Scholar]
  • 98.LeMarquand D, Pihl RO, Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psichiatry. 1994;36:395–421. doi: 10.1016/0006-3223(94)91215-7. [DOI] [PubMed] [Google Scholar]
  • 99.Panconesi A. Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain. 2008;9:71–76. doi: 10.1007/s10194-008-0020-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Flugge G, Kampen M, Mijnster MJ. Perturbations in brain monoamine systems during stress. Cell Tissue Res. 2004;315:1–14. doi: 10.1007/s00441-003-0807-0. [DOI] [PubMed] [Google Scholar]
  • 101.Sicuteri F. Quasi-phantom head pain from functional deafferentation. Clin J Pain. 1987;3:63–80. doi: 10.1097/00002508-198703020-00001. [DOI] [Google Scholar]
  • 102.Lance JW, Goadsby PJ. Mechanism and management of Headache. 7. New York: Elsevier; 2005. [Google Scholar]
  • 103.Burnstein R, Jakubowski M, Levy D. Anti-migraine. action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain. 2005;115:21–22. doi: 10.1016/j.pain.2005.01.027. [DOI] [PubMed] [Google Scholar]
  • 104.Panconesi A. Azione vasocostrittiva del sumatriptan nei vasi periferici dell’uomo. Confin Cephalal. 1994;3:5–12. [Google Scholar]
  • 105.Panconesi A, Franchi G, Anselmi B, Curradi C, Tarquini B. Amplifying effect of sumatriptan on noradrenaline venoconstriction in migraine patients. Cephalalgia. 1993;13:383–388. doi: 10.1046/j.1468-2982.1993.1306383.x. [DOI] [PubMed] [Google Scholar]
  • 106.Panconesi A, Franchi G, Anselmi B, Curradi C. On the mechanism of sumatriptan side effects. In: Fusco BM, Giacovazzo M, editors. Unilateral headache: focus on recent advances. Rome: RD Editori; 1994. pp. 111–116. [Google Scholar]
  • 107.Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: implications for the selective antimigraine action of triptans. J Neurosci. 2003;23:10988–10997. doi: 10.1523/JNEUROSCI.23-34-10988.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Villalon CM, Centurion D. Cardiovascular responses produced by 5-hydroxytryptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implication. Naunyn Schmiedebergs Arch Pharmacol. 2007;376:45–63. doi: 10.1007/s00210-007-0179-1. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Headache and Pain are provided here courtesy of BMC

RESOURCES